NATCOPHARM.NS Financials

Financials

Trends

* Timeframes marked with (Est.) are analyst estimates based on consensus data.

Details

Breakdown	2026	2025	Change %
Total Revenue	40.445.000.000	44.116.000.000	8.3%
Cost of Revenue	9.220.000.000	8.653.000.000	6.6%
Gross Profit	31.225.000.000	35.463.000.000	12.0%
	18.663.000.000	15.651.000.000	19.2%
Operating Income	12.562.000.000	19.812.000.000	36.6%
Pretax Income	14.908.000.000	22.914.000.000	34.9%
Net Income Common Stockholders	14.185.000.000	18.854.000.000	24.8%
	--	--	--
	--	--	--